Effects of PPARγ-suppression on proliferation rate, anchorage-independent growth and invasiveness of prostate cancer cells were evaluated by a proliferation assay (Fig. 2A), a soft agar assay (Fig. 2B) and an invasion assay (Fig. 2C), respectively. Here, PPARG is linked to prostate carcinoma.